Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹9.04 Cr₹41 Cr₹-60 Cr₹-73 Cr₹-108 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of EMCURE PHARMACEUTICALS is ₹9.04 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹9.04 Cr
Mar2024₹41 Cr
Mar2023₹-60 Cr
Mar2022₹-73 Cr
Mar2021₹-108 Cr

How is Deferred Tax Assets / Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹9.04 Cr
-77.74
Mar2024 ₹41 Cr
Positive
Mar2023 ₹-60 Cr
Negative
Mar2022 ₹-73 Cr
Negative
Mar2021 ₹-108 Cr -

Compare Deferred Tax Assets / Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,666.4 Cr -3.7% -5.8% 16.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-3.7%

-5.8%

16.5%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses